Showing 181 - 200 results of 230 for search '"movement disorder"', query time: 0.05s Refine Results
  1. 181
  2. 182

    Thyroid-Induced Worsening of Parkinsonian Tremor Resistant to Drugs and Subthalamic Nucleus Deep Brain Stimulation by Michal Minár, Peter Valkovič

    Published 2014-01-01
    “…A hyperthyroid state can markedly exaggerate all forms of tremor, as well as other types of movement disorders. This condition can be overlooked or masked by other symptoms. …”
    Get full text
    Article
  3. 183

    Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease by Khashayar Dashtipour, Manju Liu, Camellia Kani, Pejman Dalaie, Andre Obenaus, Daniel Simmons, Nicole M. Gatto, Mehran Zarifi

    Published 2015-01-01
    “…Twelve de novo patients with PD were recruited from the Movement Disorders Clinic, Department of Neurology, Loma Linda University. …”
    Get full text
    Article
  4. 184

    A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset by Ján Necpál, Martin Stelzer, Silvia Koščová, Michal Patarák

    Published 2016-01-01
    “…Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized by rapidly progressive dementia along with various neurological features, including myoclonus and sometimes other movement disorders. The clinical course is typically insidious and rapid, leading to an early death. …”
    Get full text
    Article
  5. 185
  6. 186

    Early Infantile Epileptic Encephalopathy in an STXBP1 Patient with Lactic Acidemia and Normal Mitochondrial Respiratory Chain Function by Dong Li, Elizabeth Bhoj, Elizabeth McCormick, Fengxiang Wang, James Snyder, Tiancheng Wang, Yan Zhao, Cecilia Kim, Rosetta Chiavacci, Lifeng Tian, Marni J. Falk, Hakon Hakonarson

    Published 2016-01-01
    “…A wide range of clinical findings have been associated with mutations in Syntaxin Binding Protein 1 (STXBP1), including multiple forms of epilepsy, nonsyndromic intellectual disability, and movement disorders. STXBP1 mutations have recently been associated with mitochondrial pathology, although it remains unclear if this phenotype is a part of the core feature for this gene disorder. …”
    Get full text
    Article
  7. 187

    Neuromodulation: clinical advances and future perspectives by ZHANG Jian⁃guo, XIE Hu⁃tao, YANG An⁃chao

    Published 2025-01-01
    “…It analyzes their efficacy and potential in the fields of movement disorders, epilepsy, pain, cognitive impairment, and neurorehabilitation. …”
    Get full text
    Article
  8. 188
  9. 189

    Clinical Practice Guidelines in Modified Tai Chi Therapy for Post-stroke Dyskinesia by Heilongjiang Association of Rehabilitation Medicine, TANG Qiang, LI Baolong, LI Hongyu, WANG Xue, MU Zichen, PANG Ruifeng, SHA Sha, ZHU Luwen

    Published 2022-06-01
    “…Individualized rehabilitation training programs can not only improve patients' movement disorders and their motivations of training, accelerate the process of rehabilitation after stroke, but also potentially save the medical cost and public health resources. …”
    Get full text
    Article
  10. 190

    Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes by Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye

    Published 2022-06-01
    “…It causes significant morbidity and disability through a plethora of symptoms, including movement disorders, sleep disturbances, and cognitive and psychiatric symptoms. …”
    Get full text
    Article
  11. 191
  12. 192

    Manganese Neurotoxicity as a Complication of Chronic Total Parenteral Nutrition by Alisha Khan, Jonathan Hingre, Amit S. Dhamoon

    Published 2020-01-01
    “…Manganese accumulation in the central nervous system creates clinical symptoms of cognitive dysfunction, behavioral changes, and movement disorders resembling Parkinson’s disease. Radiographic features of this rare clinical entity include symmetric T1 hyperintensities in the bilateral globus pallidi, with corresponding hypointensities on T2-weighted images. …”
    Get full text
    Article
  13. 193
  14. 194

    Comparative efficacy of robot-assisted therapy associated with other different interventions on upper limb rehabilitation after stroke: A protocol for a network meta-analysis. by Qian Liu, Zuoyan Liu, Yang Xu, Li Liu, Fang Wang, Fanyu Zhao, Hong Cheng, Xiuying Hu

    Published 2025-01-01
    “…<h4>Introduction</h4>Post-stroke movement disorders are common, especially upper limb dysfunction, which seriously affects the physical and mental health of stroke patients. …”
    Get full text
    Article
  15. 195
  16. 196

    Oropharyngeal Dysphagia Patient Profile Based on Flexible Endoscopic Evaluation of Swallowing by Chairul Anhar, Rizka Fathoni Perdana, Mohd Razif Mohamad Yunus

    Published 2024-12-01
    “…Preswallowing: velopharyngeal movement (14.4%), vocal cord movement disorders (28.6%), standing secretion (83.9%), penetration (38.4%), aspiration (24.1%), silent aspiration (15.2%), and impaired hypopharyngeal sensitivity (33%). …”
    Get full text
    Article
  17. 197

    Promising horizons in achondroplasia along with the development of new drugs by Keiichi Ozono, Takuo Kubota, Toshimi Michigami

    Published 2024-07-01
    “…Along with severe short stature, foramen magnum stenosis and spinal canal stenosis are major complications: the former leads to sleep apnea, breathing disorders, myelopathy, hydrocephalus, and sudden death, and the latter causes pain in the extremities, numbness, muscle weakness, movement disorders, intermittent claudication, and bladder-rectal disorders. …”
    Get full text
    Article
  18. 198

    Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson’s Disease after Deep Brain Stimulation by Hector R. Martinez, Alexis Garcia-Sarreon, Carlos Camara-Lemarroy, Fortino Salazar, María L. Guerrero-González

    Published 2018-01-01
    “…They are increasingly used in clinical settings in patients with movement disorders; however, the wide variety of systems available makes results conflicting. …”
    Get full text
    Article
  19. 199
  20. 200

    Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorder by Inna Shomer, Nofar Mor, Shaul Raviv, Noga Budick-Harmelin, Tanya Matchevich, Sharon Avkin-Nachum, Yoach Rais, Rebecca Haffner-Krausz, Ariela Haimovich, Aviv Ziv, Reut Fluss, Bruria Ben-Ze’ev, Gali Heimer, Denis N. Silachev, Vladimir L. Katanaev, Dan Dominissini

    Published 2025-03-01
    “…GNAO1-associated disorders are ultra-rare autosomal dominant conditions, which can manifest, depending on the exact pathogenic variant in GNAO1, as a spectrum of neurological phenotypes, including epileptic encephalopathy, developmental delay with movement disorders, or late-onset dystonia. There are currently no effective treatments available, apart from symptomatic options. …”
    Get full text
    Article